Buy Merck And Eli Lilly

The coming week is post options expiration week in October. The histogram below tells us that this week has a bearish tinge.

S&P 500 in Post-OPEX Week in October

Red: Probability of an up day

Blue: Percentage change

Green: Expected return

This may be the last bearish period in Q4. Here is the reasoning.

• The 1-4-10 year cycle bottomed 3 weeks ago
• October 27^th has been the seasonal low in any year
• Octobers in years ending in 2 have tended to feature significant lows
• The decline stopped at the important 3500 retracement level and rallied.

Here are some buy candidates, but defer purchase to the latter part of the week.

Merck has shown exceptional relative strength as the health care sector strengthens. In addition, the shares have risen in November almost 74% of the time since 1980. The company is due to report earnings this week. Cycles suggest a positive reaction to the announcement. The shares are likely to rise closer to $100 over the near term and higher into December.

Merck Daily Graph

Merck Monthly Histogram

Eli Lilly also shows good relative strength at the beginning of a strong period of seasonality. Price has risen in November over 70% of the time. The stock has recently hit a new closing high. A break above $340, which appears likely, could send the stock much higher into December.

Eli Lilly Daily Graph

Eli Lilly Monthly Histogram